Advances in antibody manufacturing using mammalian cells.

Area of Science:

• Biotechnology
• Biopharmaceutical Manufacturing
• Process Engineering

Background:

• Antibody production is critical for therapeutics, facing challenges in yield and quality.
• Previous antibody processing methods had limitations in efficiency and scalability.

Purpose of the Study:

• To review recent technological advancements in antibody processing.
• To highlight innovations enhancing antibody yield, quality, and cost-effectiveness.

Main Methods:

• Review of proprietary cell line development and optimized expression systems.
• Analysis of advancements in protein-free/serum-free culture media and post-translational modification control.
• Examination of innovations in bioreactor design and disposable technologies.
• Assessment of downstream processing improvements, including disposable devices, resins, and hardware.

Main Results:

• Significant improvements in antibody yields documented over the last decade.
• Widespread adoption of disposable bioreactor components leading to enhanced yields, product quality, and reduced costs.
• Innovations in downstream processing, such as disposable clarification and purification devices, have improved performance.
• Disposable technologies are a sustained driver of increased yields in both upstream and downstream processes.

Conclusions:

• Technological innovations, particularly disposable technologies, have revolutionized antibody processing.
• Continued advancements in computer technology and bioreactor design will further enhance antibody production.
• Future improvements in quality and quantity are expected, ensuring adequate supply for industry needs.